驱动基因阴性晚期非小细胞肺癌免疫检查点抑制剂一线单药及联合化疗治疗进展Progress of Immune Checkpoint Inhibitors as First-Line Monotherapy and Combined Chemotherapy for Advanced Non-Small Cell Lung Cancer with Negative Driver Genes
张学文, 陈 杰, 郑凯曼, 姜 军
临床医学进展Vol.13 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1381815, August 17 2023
PD-1抑制剂所致免疫相关不良事件的真实世界研究Real World Study of Immune-Related Adverse Events Caused by PD-1 Inhibitors
陈运旺, 姜丁乙, 邓亚亚, 张馨月, 陈哲灵, 杨 柳
临床医学进展Vol.12 No.6, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.126856, June 30 2022
免疫检查点抑制剂在PD-L1低表达/阴性晚期NSCLC患者中的治疗现状Current Status of Immune Checkpoint Inhibitor Therapy in Patients with PD-L1 Low Expression/Negative Advanced NSCLC
赵 坤, 苗健龙, 屈光义
临床医学进展Vol.13 No.5, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1351154, May 24 2023
免疫检查点抑制剂治疗黑色素瘤患者的疗效Efficacy of Immune Checkpoint Inhibitors in Treating Patients with Melanoma
马玉婷
临床医学进展Vol.13 No.7, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1371638, July 24 2023
PD-1抑制剂对非小细胞肺癌患者Mito+ T淋巴细胞免疫代谢影响模式Effect Model of PD-1 Inhibitors on Immune Metabolism of Mito+ T Lymphocytes in Patients with Non-Small Cell Lung Cancer
王 铮, 陈存海, 马学真
临床医学进展Vol.13 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.131145, January 31 2023
免疫治疗在非小细胞肺癌中的应用The Application of Immunotherapy in Non-Small Cell Lung Cancer
郭永欣, 姚 兵
临床医学进展Vol.14 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2024.141131, January 19 2024